Study title: An open-labeled study evaluating the safety and efficacy of growth hormone therapy in short children with chronic renal insufficiency
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Endocrine System Diseases [C19] | |||||
Brands: Please see report | |||||
MAH holders: Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: Somatropin | |||||
ATC code: H01AC01 | |||||
Document link: 91-003 and 91-004 EMA Pediatrics Web Synopsis.pdf | |||||
Document date: 2013-06-03 | |||||
Study number: 91-004 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |